Strengths & Weaknesses

Strengths

Strong Market Position: IIL has a strong presence in fungicides, with 12% CAGR growth and operations in over 100 countries. Exports make up 40%-45% of revenue, which reached Rs 3041 crores in fiscal 2023.

Extensive Distribution Network: With 892 product registrations and 550 global distributors, IIL has a competitive edge globally.

Diverse Products and Strong Margins: IIL offers 110+ brands with operating margins of 14.5%, expected to stay healthy at 14%-15%.

Solid Financial Profile: Strong net worth of Rs 2904 crores and low gearing, ensuring financial stability.

Weaknesses

Working Capital Intensive: The company’s operations require high working capital due to significant debtor and inventory levels, though debtor days have improved in recent years.

Weather and Regulatory Risks: IIL’s performance is sensitive to rainfall patterns, which affect agricultural production. Additionally, changing regulations or product approval processes could impact revenue and profitability.

Balance Sheet	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Equity Capital	21.35	21.35	21.35	21.35	21.35	21.35
Reserves	3973.00	2896.18	2201.50	1931.35	1905.67	1979.60
Total Equity	3994.35	2917.53	2222.85	1952.70	1927.02	2000.95
Borrowings	53.32	116.28	175.76	278.52	422.49	527.94
Provision	10.83	15.10	17.47	10.79	25.91	23.95
Other Non-Current Liabilities	226.37	124.17	41.03	19.07	25.02	20.55
Total Non Current Liabilities	290.52	255.55	234.26	308.38	473.42	572.44
Borrowings	309.97	442.71	502.95	493.33	587.14	596.80
Other Current Liabilities	561.79	516.77	884.43	592.85	564.23	736.71
Total Current Liabilities	871.76	959.48	1387.38	1086.18	1151.37	1333.51
Equity + Liabilities	5156.63	4132.56	3844.49	3347.26	3551.81	3906.90
Fixed Assets (incl. WIP)	585.10	607.07	613.56	809.76	700.16	737.26
Other Non Current Assets	2590.32	1694.13	1112.16	924.07	1325.55	1388.69
Total Non Current Assets	3175.42	2301.20	1725.72	1733.83	2025.71	2125.95
Trade Receivables	902.88	758.01	784.71	774.88	772.03	823.94
Cash & Cash Equivalents	406.57	231.55	519.85	316.10	194.18	188.20
Other Current Assets	671.46	840.48	813.85	503.49	559.89	768.81
Total Current Assets	1980.91	1830.04	2118.41	1594.47	1526.10	1780.95
Assets Held for Sale	0.30	1.32	0.36	18.96	0.00	0.00
Total Assets	5156.63	4132.56	3844.49	3347.26	3551.81	3906.90

Profit & Loss	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue from Operations	3,068.77	3,046.63	2,795.09	2,428.95	2,216.33	2,251.76
Growth %	0.73%	9.00%	15.07%	9.59%	-1.57%	0
Operating Expenses	2,626.33	2,667.76	2,438.62	1,974.22	1,930.60	1,875.04
Growth %	-1.55%	9.40%	23.52%	2.26%	2.96%	0
Operating Profit	442.44	378.87	356.47	454.73	285.73	376.72
Op. Profit Margin %	14.42%	12.44%	12.75%	18.72%	12.89%	16.73%
Other Income	49.94	48.82	75.03	11.88	19.55	12.44
Finance Costs	39.34	46.07	45.23	64.73	89.88	68.83
Depreciation	89.36	86.84	89.87	111.74	118.10	91.36
Profit Before Tax	0.00	10.32	0.00	149.54	31.41	0.00
Tax	363.68	284.46	296.40	140.60	65.89	228.97
Tax %	89.76	97.16	89.36	93.06	-12.79	43.29
Profit After Tax	2.92%	3.19%	3.20%	3.83%	-0.58%	1.92%
Growth %	46.25%	-9.53%	335.51%	-39.58%	-57.63%	0
PAT %	8.93%	6.15%	7.41%	1.96%	3.55%	8.25%
Diluted EPS	155.57	112.94	102.49	31.35	44.37	88.40

Shareholding Pattern

Color	Shareholder	Holding
	AB Inbev Asia B V	63.00%
	Anheuser Busch Inbev Breweries Private Limited	34.77%
	Sabmilier India Holdings	1.36%
	Austindia Pty Limited	0.40%
	Others	0.47%

Fundamentals

Quick Insights

Strong Market Position: IIL has a strong presence in fungicides, with 12% CAGR growth and operations in over 100 countries. Exports make up 40%-45% of revenue, which reached Rs 3041 crores in fiscal 2023.

Market Cap₹107,850.72 Cr

PE Ratio7.71

EPS₹155.57

Dividend Yield-

Book Value₹44.44 Cr

Debt/Equity0.09

Price/Book27

Price/Sales-

Industry PE-

Sales₹3,068.77 Cr

Profit After Tax₹273.92 Cr

Share Capital₹21.35 Cr

Shares Outstanding-

ISININE071I01016

SectorChemicals/Manufacturing

Symbol-

About Company

Indofil Industries Limited (IIL), part of the KK Modi Group, is a leading global manufacturer of agrochemicals and specialty chemicals. Known for its expertise in Mancozeb, the world’s top-selling fungicide

Latest News

No news available.

Annual Reports

FY FY FY FY FY

Board of Directors

Dr. Bina ModiChairperson & Managing Director

Ms. Charu ModiExecutive Director

Mr. Samir ModiNon-Executive & Non-Independent Director

Ms. Aliya ModiNon-Executive & Non-Independent Director

Mr. S. LakshminarayananNon-Executive & Independent Director

Mr. Mayur MaheshwariNominee Director

Mr. M. N. ThakkarNon-Executive & Independent Director

Dr. Atchutuni L. RaoWhole time Director - Operations

Senior Management

Dr. Bina Modi Managing Director

CS Jayni GadaCompany Secretary

Balance Sheet

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Equity Capital

21.35

Reserves

3973.00

2896.18

2201.50

1931.35

1905.67

1979.60

Total Equity

3994.35

2917.53

2222.85

1952.70

1927.02

2000.95

Borrowings

53.32

116.28

175.76

278.52

422.49

527.94

Provision

10.83

15.10

17.47

10.79

25.91

23.95

Other Non-Current Liabilities

226.37

124.17

41.03

19.07

25.02

20.55

Total Non Current Liabilities

290.52

255.55

234.26

308.38

473.42

572.44

Borrowings

309.97

442.71

502.95

493.33

587.14

596.80

Other Current Liabilities

561.79

516.77

884.43

592.85

564.23

736.71

Total Current Liabilities

871.76

959.48

1387.38

1086.18

1151.37

1333.51

Equity + Liabilities

5156.63

4132.56

3844.49

3347.26

3551.81

3906.90

Fixed Assets (incl. WIP)

585.10

607.07

613.56

809.76

700.16

737.26

Other Non Current Assets

2590.32

1694.13

1112.16

924.07

1325.55

1388.69

Total Non Current Assets

3175.42

2301.20

1725.72

1733.83

2025.71

2125.95

Trade Receivables

902.88

758.01

784.71

774.88

772.03

823.94

Cash & Cash Equivalents

406.57

231.55

519.85

316.10

194.18

188.20

Other Current Assets

671.46

840.48

813.85

503.49

559.89

768.81

Total Current Assets

1980.91

1830.04

2118.41

1594.47

1526.10

1780.95

Assets Held for Sale

0.30

1.32

0.36

18.96

0.00

Total Assets

5156.63

4132.56

3844.49

3347.26

3551.81

3906.90

Profit & Loss

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Revenue from Operations

3,068.77

3,046.63

2,795.09

2,428.95

2,216.33

2,251.76

Growth %

0.73%

9.00%

15.07%

9.59%

-1.57%

Operating Expenses

2,626.33

2,667.76

2,438.62

1,974.22

1,930.60

1,875.04

Growth %

-1.55%

9.40%

23.52%

2.26%

2.96%

Operating Profit

442.44

378.87

356.47

454.73

285.73

376.72

Op. Profit Margin %

14.42%

12.44%

12.75%

18.72%

12.89%

16.73%

Other Income

49.94

48.82

75.03

11.88

19.55

12.44

Finance Costs

39.34

46.07

45.23

64.73

89.88

68.83

Depreciation

89.36

86.84

89.87

111.74

118.10

91.36

Profit Before Tax

0.00

10.32

0.00

149.54

31.41

0.00

Tax

363.68

284.46

296.40

140.60

65.89

228.97

Tax %

89.76

97.16

89.36

93.06

-12.79

43.29

Profit After Tax

2.92%

3.19%

3.20%

3.83%

-0.58%

1.92%

Growth %

46.25%

-9.53%

335.51%

-39.58%

-57.63%

PAT %

8.93%

6.15%

7.41%

1.96%

3.55%

8.25%

Diluted EPS

155.57

112.94

102.49

31.35

44.37

88.40

Color

Shareholder

Holding

AB Inbev Asia B V

63.00%

Anheuser Busch Inbev Breweries Private Limited

34.77%

Sabmilier India Holdings

1.36%

Austindia Pty Limited

0.40%

Others

0.47%

FAQs – Buying Unlisted Shares

What are unlisted shares?+

Unlisted shares are stocks of companies that are not listed on any stock exchange like NSE or BSE. They are traded in the over-the-counter (OTC) market through dealers, brokers, and private transactions.

How is the price of an unlisted share decided?+

Unlike listed shares, there’s no central marketplace or live order book. Prices are based on demand and supply, dealer quotes, and recent transaction trends. This leads to price fragmentation — different dealers can quote very different prices for the same stock.

Why should I compare prices before buying?+

Because the same share can be available at a 5–20% price difference depending on the dealer. Not comparing means you could be paying a premium for no reason — directly impacting your returns.

Is buying unlisted shares risky?+

Yes, like any investment, unlisted shares carry risks — including liquidity risk (harder to sell), company performance risk, and price transparency issues. Comparing prices helps reduce one avoidable risk — overpaying.

How can I know if the price I’m getting is fair?+

You can check recent transaction prices, ask multiple dealers, and soon — use our price comparison platform to instantly see live market quotes.

What documents are required to buy unlisted shares?+

Typically: PAN Card Demat Account details KYC documents (address proof, ID proof)

How do I sell unlisted shares?+

You can sell them via a dealer, private buyer, or once the company gets listed on a stock exchange. Having access to multiple dealer quotes helps you get the best selling price.

Can dealers lose business if they don’t offer the best price?+

Absolutely. If an investor finds a better price elsewhere, they’ll switch — often for good. That’s why transparent pricing protects both investors and dealers.

How soon will I receive the shares after purchase?+

Usually within T+2 to T+7 days after payment and documentation, depending on the dealer and the company’s transfer process.

Do I need to be an accredited investor to buy unlisted shares?+

No, but you must meet the regulatory requirements under SEBI guidelines and have a valid Demat account.

Indofil Industries ltd

Strengths

Weaknesses

Quick Insights

Quick Insights

Strengths

Weaknesses

FAQs – Buying Unlisted Shares